Peregrine Market Access

What Peregrine Market Access does

Peregrine Market Access is a healthcare market access consultancy that helps pharmaceutical, biotechnology, and medical device companies secure payer coverage and accelerate patient access to therapies. Founded in 2016 and headquartered in Saratoga Springs, New York, the firm operates in the 101–250 employee band and delivers professional services across eight integrated disciplines: Strategy and Consulting, Communications, Value Chain Public Relations, Digital Modeling, Market Insights, Publication and Media Strategy, Reimbursement Solutions, and Contract Account and Sales. Its core technology combines real-world evidence analytics with proprietary AI-powered insights and Dynamic Access Decision Models to produce payer-facing value stories that lower coverage hurdles for client therapies.

The company generates revenue through custom-quoted B2B consulting engagements sold through direct enterprise sales and specialized contract account teams targeting life sciences decision-makers. Pricing is not publicly disclosed, consistent with project-based advisory work. John Guarino serves as President and Managing Partner. In 2025, Peregrine was acquired by Klick Group, the world's largest independent life sciences commercialization partner, and has been repositioned within Klick Health as the "Klick Market Access" service line, gaining access to Klick's 1,500+ professionals, nearly 250 post-graduate in-house medical experts, and offices across North America, Europe, Asia-Pacific, and Latin America.

The acquisition was financed alongside a growth investment from healthcare-focused private equity firm Linden Capital Partners and Singapore sovereign wealth fund GIC, which replaced Klick's prior partnership with GTCR. Distribution is primarily direct enterprise sales, supplemented by thought-leadership content through Klick Ideas Exchange (IDX), the Klick Wire newsletter, case studies, and industry events.

Name

Peregrine Market Access

Legal name

Peregrine Market Access

Website

https://peregrinemarketaccess.com

Company type

Private

Founded year

2016

Operating status

Acquired

Headcount range

101–250 employees

Short description

Peregrine Market Access is a healthcare market access consultancy serving pharmaceutical, biotechnology, and medical device companies, leveraging real-world evidence analytics and proprietary AI-powered Decision Models to support payer coverage decisions. Now operates within Klick Health's life sciences commercialization ecosystem.

Ownership category

akta.pro rank

Product category

Healthcare Market Access Consulting

NAICS

Professional, Scientific, and Technical Services (54), Marketing Consulting Services (541613)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Access Policy, Advocacy & Stakeholder Management (HLAIAKAL)

akta.pro secondary industry

Market Access, Pricing & Reimbursement (Evidence Generation) FSP (HLAGAOAN)

Keywords

• Market access consulting
• Healthcare market access
• Pharma payer strategy
• Real-world evidence analytics
• Life sciences commercialization

Headquarters

HQ city

Saratoga Springs

HQ country

United States

HQ region

North America

Offices7 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Market Access Consulting Services: Professional consulting services for life sciences companies seeking payer coverage and market access support. Delivered through expert-led departments across eight disciplines including strategy, communications, reimbursement solutions, and contract account management.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Peregrine Market Access provides market access consulting services for life sciences companies, including pre-approval strategies, payer engagement, reimbursement solutions, digital decision modeling, market insights, value chain communications, and specialized contract account teams. The firm combines real-world evidence analytics, AI-powered insights, and proprietary Access Decision Models to help pharmaceutical, biotechnology, and medical device companies demonstrate therapy value to payers, providers, and patients and accelerate coverage decisions.

Product overview

Klick Market Access is a core service offering within Klick Health's ecosystem — the world's largest independent life sciences commercialization partner. It operates as part of a unified platform that integrates medical, scientific, creative, regulatory, market access, and data expertise across eight essential disciplines including Strategy and Consulting, Value Chain Public Relations, Digital Modeling, Market Insights, Reimbursement Solutions, and Contract Account teams. Peregrine Market Access was acquired to enhance these market access capabilities. The service is powered by proprietary data models and industry-leading AI to deliver measurable impact through pre-approval strategies and Dynamic Access Decision Models.

Differentiator

Problem solved

Functional benefit

Products and services

• Market Access Consulting Services
• Strategy and Consulting
• Reimbursement Solutions
• Contract Account and Sales Team
• Digital Modeling / Access Decision Models
• Value Chain Public Relations / Communications
• Market Insights and Publication/Media Strategy

Quantifiable outcome

• Lowering coverage hurdles for therapies
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature4 records

Partnerships

Two partnerships are on record, tiered core and minor.

• Klick Group (Parent)coreStrategic or Co-development Partner · 4 July 2025Peregrine Market Access was acquired by Klick Group as part of their acquisition strategy. Now operates as part of Klick Health's Market Access division, bringing expertise in data-powered value strategies for healthcare coverage and patient care.
• Ward6minorStrategic or Co-development PartnerKlick Group acquired Ward6's Singapore operations alongside Peregrine Market Access, expanding their Asia-Pacific presence and digital capabilities.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• EVERSANA: End-to-end life sciences commercialization services company covering market access, patient services, and reimbursement — a broader incumbent whose access offerings directly overlap Peregrine's reimbursement solutions and contract account teams.
• IQVIA: Largest life sciences commercialization and data services firm; offers market access, RWE, HEOR, and consulting as part of a much broader portfolio — competes with Peregrine but at vastly greater scale and across adjacent services.
• Syneos Health: Clinical and commercial services company offering consulting, market access, and commercialization solutions to biopharma — overlaps with Peregrine's communications, reimbursement, and contract account services within a broader clinical-to-commercial platform.
• McKinsey & Company (Pharma Practice): Top-tier global strategy consulting firm with substantial pharma and biotech practices — competes with Peregrine on top-tier market access strategy and value communications mandates via scale economics.

Direct peers

• ZS Associates: Global management consulting firm with deep pharma and biotech practices spanning market access, pricing, HEOR, and real-world evidence — the most directly comparable pure-play market access consultancy to Peregrine in size, methodology, and customer base.
• L.E.K. Consulting: Global strategy consultancy with a substantial life sciences practice covering commercial, pricing, market access, and launch strategy — competes with Peregrine for pharma client mandates at the strategy and consulting layer.
• PRECISIONvalue: Specialized market access, pricing, and health economics consulting within Precision Medicine Group — directly competes with Peregrine on access strategy, payer engagement, value communications, and HEOR for biopharma clients.
• Xcenda: Market access consulting and research firm (part of Cencora/formerly AmerisourceBergen) providing HEOR, reimbursement, and payer insights to pharma — closely comparable to Peregrine's evidence-generation and reimbursement advisory offerings.
• Trinity Partners: Boutique life sciences strategy consulting firm focused on biopharma commercial, access, and evidence-generation engagements — similar firm size, customer profile, and service scope to Peregrine.

Emerging players

• Charles River Associates: Life sciences strategy and economics consulting firm with capabilities in market access, pricing, and HEOR — comparable in focus and customer base to Peregrine though smaller in dedicated access practice.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/PeregrineMA_
• Facebookfacebook.com/peregrinemarketaccess
• LinkedInlinkedin.com/company/peregrine-market-access

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Peregrine Market Access